版本:
中国

BRIEF-Teleflex commences phase I clinical study of RePlas freeze-dried plasma

May 15 Teleflex Inc

* Teleflex (TFX) announces commencement of phase i clinical study (FDP-1) of RePlas™ freeze-dried plasma

* Teleflex inc- RePlas, a lyophilized fresh frozen plasma product, being developed in collaboration with U.S. Army medical materiel development activity Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐